Dualyx
Cambridge, United States· Est.
Dualyx develops bispecific antibody therapies designed to modulate the immune system for treating autoimmune and inflammatory diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $40M
About
Dualyx develops bispecific antibody therapies designed to modulate the immune system for treating autoimmune and inflammatory diseases.
ImmunologyAntibodiesBiologics
Funding History
1Total raised:$40M
PIPE$40M